Tegoyes 15 mg Capsule

Tegoyes 15mg Capsule is engineered to optimize the performance of 5-fluorouracil (5-FU) within the body. By providing the medication in an oral capsule form, it offers patients the flexibility of home-based treatment while maintaining the clinical outcomes associated with hospital-administered infusions.

Key Clinical Benefits of TEGOYES

• Enhanced Potency: Gimeracil inhibits the enzyme DPD, ensuring that high levels of the cancer-fighting agent remain in the bloodstream for longer periods.

• Reduced Toxicity: Oteracil specifically concentrates in the gut tissues to block the activity of 5-FU there, significantly reducing the risk of severe diarrhea and gastrointestinal distress.

• Targeted Efficacy: Effectively shrinks tumors and slows disease progression in metastatic or advanced gastric cancer cases.

• Convenience: Eliminates the need for continuous intravenous catheters, improving the patient's quality of life during chemotherapy cycles.

Administration & Safety Protocols

1. Dosing Schedule: Usually taken twice daily (morning and evening) for 21 consecutive days, followed by a 7-day rest period. This constitutes one cycle.

2. Timing: TEGOYES should be taken at least 1 hour before or 1 hour after meals.

3. Whole Capsule: Swallow the capsules whole with water. Do not open, chew, or dissolve them.

4. Combination Therapy: When used with Cisplatin, specific hydration protocols must be followed as directed by your oncologist.

5. Monitoring: Regular blood counts (CBC) and kidney function tests are mandatory, as the medication can affect bone marrow and renal health.